News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
742,669 Results
Type
Article (43888)
Company Profile (318)
Press Release (698450)
Multimedia
Podcasts (116)
Webinars (19)
Section
Business (211030)
Career Advice (2110)
Deals (36764)
Drug Delivery (124)
Drug Development (83427)
Employer Resources (176)
FDA (16854)
Job Trends (15505)
News (357452)
Policy (34141)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2617)
Accelerated approval (34)
Adcomms (26)
Allergies (151)
Alliances (51592)
ALS (174)
Alzheimer's disease (1699)
Antibody-drug conjugate (ADC) (327)
Approvals (17121)
Artificial intelligence (543)
Autoimmune disease (163)
Automation (42)
Bankruptcy (373)
Best Places to Work (11772)
BIOSECURE Act (21)
Biosimilars (199)
Biotechnology (188)
Bladder cancer (160)
Brain cancer (61)
Breast cancer (655)
Cancer (4937)
Cardiovascular disease (421)
Career advice (1789)
Career pathing (37)
CAR-T (287)
CDC (49)
Celiac Disease (2)
Cell therapy (763)
Cervical cancer (36)
Clinical research (71215)
Collaboration (1776)
Company closure (4)
Compensation (1188)
Complete response letters (65)
COVID-19 (2789)
CRISPR (99)
C-suite (890)
Cystic fibrosis (148)
Data (6345)
Decentralized trials (2)
Denatured (36)
Depression (138)
Diabetes (510)
Diagnostics (6797)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (263)
Drug pricing (202)
Drug shortages (31)
Duchenne muscular dystrophy (236)
Earnings (92002)
Editorial (61)
Employer branding (21)
Employer resources (155)
Events (120380)
Executive appointments (1008)
FDA (20043)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1499)
Gene editing (206)
Generative AI (46)
Gene therapy (618)
GLP-1 (1015)
Government (4810)
Grass and pollen (7)
Guidances (385)
Healthcare (19070)
HIV (62)
Huntington's disease (46)
IgA nephropathy (86)
Immunology and inflammation (266)
Immuno-oncology (61)
Indications (120)
Infectious disease (3067)
Inflammatory bowel disease (202)
Inflation Reduction Act (14)
Influenza (119)
Intellectual property (259)
Interviews (327)
IPO (16922)
IRA (57)
Job creations (4070)
Job search strategy (1499)
JPM (64)
Kidney cancer (16)
Labor market (86)
Layoffs (577)
Leadership (34)
Legal (8430)
Liver cancer (92)
Longevity (16)
Lung cancer (666)
Lymphoma (385)
Machine learning (43)
Management (60)
Manufacturing (837)
MASH (171)
Medical device (13896)
Medtech (13953)
Mergers & acquisitions (20917)
Metabolic disorders (1312)
Multiple sclerosis (164)
NASH (17)
Neurodegenerative disease (328)
Neuropsychiatric disorders (92)
Neuroscience (2975)
Neurotech (1)
NextGen: Class of 2026 (6648)
Non-profit (4564)
Now hiring (68)
Obesity (620)
Opinion (289)
Ovarian cancer (168)
Pain (218)
Pancreatic cancer (232)
Parkinson's disease (286)
Partnered (34)
Patents (515)
Patient recruitment (502)
Peanut (60)
People (60965)
Pharmaceutical (90)
Pharmacy benefit managers (31)
Phase 1 (22105)
Phase 2 (31311)
Phase 3 (23461)
Pipeline (5507)
Policy (303)
Postmarket research (2656)
Preclinical (9391)
Press Release (68)
Prostate cancer (242)
Psychedelics (50)
Radiopharmaceuticals (290)
Rare diseases (881)
Real estate (6307)
Recruiting (72)
Regulatory (25463)
Reports (53)
Research institute (2443)
Resumes & cover letters (361)
Rett syndrome (27)
RNA editing (17)
RSV (81)
Schizophrenia (158)
Series A (246)
Series B (194)
Service/supplier (11)
Sickle cell disease (101)
Special edition (25)
Spinal muscular atrophy (160)
Sponsored (43)
Startups (3767)
State (2)
Stomach cancer (19)
Supply chain (107)
Tariffs (96)
The Weekly (78)
Vaccines (1043)
Venture capital (91)
Weight loss (405)
Women's health (94)
Worklife (18)
Date
Today (32)
Last 7 days (587)
Last 30 days (2278)
Last 365 days (30246)
2026 (4077)
2025 (30683)
2024 (35771)
2023 (40639)
2022 (51810)
2021 (56335)
2020 (54795)
2019 (47405)
2018 (35784)
2017 (33152)
2016 (32687)
2015 (38633)
2014 (32542)
2013 (27651)
2012 (29748)
2011 (30496)
2010 (28517)
Location
Africa (800)
Alabama (85)
Alaska (7)
Arizona (318)
Arkansas (14)
Asia (42188)
Australia (6758)
California (11471)
Canada (3344)
China (1144)
Colorado (483)
Connecticut (486)
Delaware (345)
Europe (90520)
Florida (1717)
Georgia (361)
Hawaii (3)
Idaho (61)
Illinois (890)
India (73)
Indiana (537)
Iowa (22)
Japan (448)
Kansas (127)
Kentucky (40)
Louisiana (26)
Maine (72)
Maryland (1404)
Massachusetts (8254)
Michigan (330)
Minnesota (635)
Mississippi (6)
Missouri (128)
Montana (32)
Nebraska (28)
Nevada (123)
New Hampshire (79)
New Jersey (3049)
New Mexico (29)
New York (3026)
North Carolina (1492)
North Dakota (8)
Northern California (5604)
Ohio (340)
Oklahoma (22)
Oregon (46)
Pennsylvania (2326)
Puerto Rico (24)
Rhode Island (48)
South America (1176)
South Carolina (68)
South Dakota (1)
Southern California (4470)
Tennessee (177)
Texas (1771)
United States (40786)
Utah (343)
Vermont (1)
Virginia (281)
Washington D.C. (81)
Washington State (938)
West Virginia (4)
Wisconsin (117)
Wyoming (2)
742,669 Results for "titan pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners
January 13, 2026
·
1 min read
Press Releases
Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners
December 2, 2025
·
4 min read
Press Releases
Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd.
June 4, 2025
·
5 min read
Press Releases
Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq
November 28, 2024
·
3 min read
Press Releases
Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock
April 14, 2025
·
2 min read
Press Releases
U.S. Military Study Identifies TITAN CSR® Retractor as Top Surgical Retractor for Deployed Trauma Care
August 12, 2025
·
4 min read
Biotech Bay
Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria
Titan Pharmaceuticals, Inc. announced that by letter dated January 24, 2024, the Company was notified by The Nasdaq Stock Market LLC that the Company has regained compliance with the minimum $1.00 bid price requirement and otherwise satisfies all applicable criteria for continued listing on The Nasdaq Capital Market.
January 25, 2024
·
2 min read
Press Releases
Citius Pharmaceuticals, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR™
February 13, 2026
·
12 min read
Press Releases
Aucta Pharmaceuticals, Inc. (“Aucta Pharmaceuticals”) prepares for the launch of PYQUVI™ (deflazacort) oral suspension, the first of a new branded-generic rare disease product line
February 8, 2026
·
7 min read
Biotech Bay
Titan Pharmaceuticals Announces Sale of Certain ProNeura Assets
Titan Pharmaceuticals, Inc. announced that it has entered into an Asset Purchase Agreement with Fedson, Inc., a Delaware Corporation, for the sale of certain ProNeura assets including Titan’s portfolio of drug addiction products, in addition to other early development programs based on the ProNeura drug delivery technology.
July 27, 2023
·
3 min read
1 of 74,267
Next
